Nomura Holdings
AMRI

Nomura Holdings’s Albany Molecular Research Inc AMRI Stock Holding History

Nomura Holdings’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-11,400
Closed -$200K – 2222
2015
Q3 		$200K Buy
+11,400
New +$232K ﹤0.01% 1417

Other funds holding AMRI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nomura Holdings's AMRI Position: Q4 2015 in Review

Nomura Holdings sold out of Albany Molecular Research Inc (AMRI) in Q4 2015, closing a stake of 11,400 shares — an estimated $200K sold.

Nomura Holdings first reported a position in AMRI in Q3 2015 and held it in 1 quarter. The position peaked at $200K in Q3 2015. 151 funds tracked by Wall St. Rank hold AMRI as of Q4 2015.

  • Nomura Holdings reported no remaining Albany Molecular Research Inc position as of Q4 2015 after selling out during the quarter.
  • Nomura Holdings sold 11,400 Albany Molecular Research Inc shares in Q4 2015, an estimated $200K.
  • Nomura Holdings first reported a position in Albany Molecular Research Inc in Q3 2015 and held it in 1 quarter.
  • Nomura Holdings's Albany Molecular Research Inc position peaked at $200K in Q3 2015.
  • 151 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q4 2015.

Based on Nomura Holdings's 13F filing for Q4 2015, filed 12 Feb 2016.